159 related articles for article (PubMed ID: 37565549)
1. Hepatic transcriptome signatures in mice and humans with nonalcoholic fatty liver disease.
Ding Y; Dai X; Bao M; Xing Y; Liu J; Zhao S; Liu E; Yuan Z; Bai L
Animal Model Exp Med; 2023 Aug; 6(4):317-328. PubMed ID: 37565549
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
[TBL] [Abstract][Full Text] [Related]
3. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature.
Almanza D; Gharaee-Kermani M; Zhilin-Roth A; Rodriguez-Nieves JA; Colaneri C; Riley T; Macoska JA
Dig Dis Sci; 2019 May; 64(5):1257-1269. PubMed ID: 30519850
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease-associated DNA methylation and gene expression alterations in the livers of Collaborative Cross mice fed an obesogenic high-fat and high-sucrose diet.
Tryndyak VP; Willett RA; Avigan MI; Sanyal AJ; Beland FA; Rusyn I; Pogribny IP
Epigenetics; 2022 Nov; 17(11):1462-1476. PubMed ID: 35324388
[TBL] [Abstract][Full Text] [Related]
6. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
[TBL] [Abstract][Full Text] [Related]
7. Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis.
Chatterjee A; Basu A; Das K; Singh P; Mondal D; Bhattacharya B; Roychoudhury S; Majumder PP; Chowdhury A; Basu P
Ann Hepatol; 2020; 19(5):472-481. PubMed ID: 32682086
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J
Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
10. Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling.
Kennedy L; Hargrove L; Demieville J; Bailey JM; Dar W; Polireddy K; Chen Q; Nevah Rubin MI; Sybenga A; DeMorrow S; Meng F; Stockton L; Alpini G; Francis H
Am J Pathol; 2018 Mar; 188(3):600-615. PubMed ID: 29248461
[TBL] [Abstract][Full Text] [Related]
11. CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice.
Xu L; Chen Y; Nagashimada M; Ni Y; Zhuge F; Chen G; Li H; Pan T; Yamashita T; Mukaida N; Kaneko S; Ota T; Nagata N
Metabolism; 2021 Dec; 125():154914. PubMed ID: 34656648
[TBL] [Abstract][Full Text] [Related]
12. Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes.
Liu XL; Ming YN; Zhang JY; Chen XY; Zeng MD; Mao YM
Exp Mol Med; 2017 Jan; 49(1):e283. PubMed ID: 28082742
[TBL] [Abstract][Full Text] [Related]
13. Effect of an obesogenic high-fat and high-sucrose diet on hepatic gene expression signatures in male Collaborative Cross mice.
Tryndyak VP; Willett RA; Nagumalli SK; Li D; Avigan MI; Beland FA; Rusyn I; Pogribny IP
Am J Physiol Gastrointest Liver Physiol; 2023 Mar; 324(3):G232-G243. PubMed ID: 36625475
[TBL] [Abstract][Full Text] [Related]
14. Multiomics study of nonalcoholic fatty liver disease.
Sveinbjornsson G; Ulfarsson MO; Thorolfsdottir RB; Jonsson BA; Einarsson E; Gunnlaugsson G; Rognvaldsson S; Arnar DO; Baldvinsson M; Bjarnason RG; ; Eiriksdottir T; Erikstrup C; Ferkingstad E; Halldorsson GH; Helgason H; Helgadottir A; Hindhede L; Hjorleifsson G; Jones D; Knowlton KU; Lund SH; Melsted P; Norland K; Olafsson I; Olafsson S; Oskarsson GR; Ostrowski SR; Pedersen OB; Snaebjarnarson AS; Sigurdsson E; Steinthorsdottir V; Schwinn M; Thorgeirsson G; Thorleifsson G; Jonsdottir I; Bundgaard H; Nadauld L; Bjornsson ES; Rulifson IC; Rafnar T; Norddahl GL; Thorsteinsdottir U; Sulem P; Gudbjartsson DF; Holm H; Stefansson K
Nat Genet; 2022 Nov; 54(11):1652-1663. PubMed ID: 36280732
[TBL] [Abstract][Full Text] [Related]
15. Integration analysis identifies the role of metallothionein in the progression from hepatic steatosis to steatohepatitis.
Li X; Zhong S; Sun Y; Huang X; Li Y; Wang L; Wu Y; Yang M; Yuan HX; Liu J; Zang S
Front Endocrinol (Lausanne); 2022; 13():951093. PubMed ID: 36329886
[TBL] [Abstract][Full Text] [Related]
16. Lipocalin-2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high-fat diet-fed Ob/Ob mice.
Kim KE; Lee J; Shin HJ; Jeong EA; Jang HM; Ahn YJ; An HS; Lee JY; Shin MC; Kim SK; Yoo WG; Kim WH; Roh GS
Hepatology; 2023 Mar; 77(3):888-901. PubMed ID: 35560370
[TBL] [Abstract][Full Text] [Related]
17. Cellular and molecular alterations in a human hepatocellular in vitro model of nonalcoholic fatty liver disease development and stratification.
Willett RA; Tryndyak VP; Beland FA; Pogribny IP
J Environ Sci Health C Toxicol Carcinog; 2024; 42(1):74-92. PubMed ID: 38105681
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
Boland ML; Oldham S; Boland BB; Will S; Lapointe JM; Guionaud S; Rhodes CJ; Trevaskis JL
World J Gastroenterol; 2018 Apr; 24(16):1748-1765. PubMed ID: 29713129
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]